Biology Reference
In-Depth Information
51 Stebler C, Tichelli A, Dazzi H, Gratwohl A, Nissen C, Speck B (1990) High-dose recombinant
human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal noc-
turnal hemoglobinuria: A pilot study.
Exp Hematol
18: 1204-1208
52 Bessho M, Jinnai I, Matsuda A, Saito M, Hirashima K (1990) Improvement of anemia by recom-
binant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia.
Int J Cell
Cloning
8: 445-458
53 Stein RS, Abels RI, Krantz SB (1991) Pharmacologic doses of recombinant human erythropoietin
in the treatment of myelodysplastic syndromes.
Blood
78: 1658-1663
54 Hellstrom E, Birgegard G, Lockner D, Helmers C, Ost A, Wide L (1991) Treatment of myelodys-
plastic syndromes with recombinant human erythropoietin.
Eur J Haematol
47: 355-360
55 Casadevall N, Belanger C, Goy A, Varet B, Lang J, Poisson D (1992) High-dose recombinant
human erythropoietin administered intravenously for the treatment of anaemia in myelodysplastic
syndromes.
Acta Haematol
87: 25-27
56 Goy A, Belanger C, Casadevall N, Picard F, Guesnu M, Jaulmes D, Poisson D, Varet B (1993)
High doses of intravenous recombinant erythropoietin for the treatment of anaemia in myelodys-
plastic syndrome.
Br J Haematol
84: 232-237
57 Mohr B, Herrmann R, Huhn D (1993) Recombinant human erythropoietin in patients with
myelodysplastic syndrome and myelofibrosis.
Acta Haematol
90: 65-70
58 Bowen D, Culligan D, Jacobs A (1991) The treatment of anaemia in the myelodysplastic syn-
dromes with recombinant human erythropoietin.
Br J Haematol
77: 419-423
59 Rafanelli D, Grossi A, Longo G, Vannucchi AM, Bacci P, Ferrini PR (1992) Recombinant human
erythropoietin for treatment of myelodysplastic syndromes.
Leukemia
6: 323-327
60 Ghio R, Balleari E, Ballestrero A, Gatti AM, Mareni C, Massa G, Patrone F, Sessarego M, Timitilli
S (1993) Subcutaneous recombinant human erythropoietin for the treatment of anemia in
myelodysplastic syndromes.
Acta Haematol
90: 58-64
61 Aloe Spiriti MA, Petti MC, Latagliata R, Avvisati G, De Gregoris C, Proia S, Fazi P, Jaalouk G,
Mancini M, Spadea A et al. (1993) Recombinant human erythropoietin in the treatment of
myelodysplastic syndromes. An interim report.
Haematologica
78:123-126
62 Stone RM, Bernstein SH, Demetri G, Facklam DP, Arthur K, Andersen J, Aster JC, Kufe D (1994)
Therapy with recombinant human erythropoietin in patients with myelodysplastic syndromes.
Leuk Res
18: 769-776
63 Stasi R, Brunetti M, Bussa S, Conforti M, Di Giulio C, Crescenzi A, Terzoli E, Vecchione A,
Pagano A (1997) Response to recombinant human erythropoietin in patients with myelodysplas-
tic syndromes.
Clin Cancer Res
3: 733-739
64 Hansen PB, Johnsen HE, Hippe E, Hellstrom-Lindberg E, Ralfkiaer E (1993) Recombinant human
granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin may
improve anemia in selected patients with myelodysplastic syndromes.
Am J Hematol
44: 229-236
65 Negrin RS, Stein R, Vardiman J, Doherty K, Cornwell J, Krantz S, Greenberg PL (1993)
Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte
colony-stimulating factor in combination with erythropoietin.
Blood
82: 737-743
66 Negrin RS, Stein R, Doherty K, Cornwell J, Vardiman J, Krantz S, Greenberg PL (1996)
Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human
granulocyte colony-stimulating factor and erythropoietin: Evidence for
in vivo
synergy.
Blood
87:
4076-4081
67 Runde V, Aul C, Ebert A, Grabenhorst U, Schneider W (1995) Sequential administration of recom-
binant human granulocyte-macrophage colony-stimulating factor and human erythropoietin for
treatment of myelodysplastic syndromes.
Eur J Haematol
54: 39-45
68 Imamura M, Kobayashi M, Kobayashi S, Yoshida K, Mikuni C, Ishikawa Y, Matsumoto S,
Sakamaki S, Niitsu Y, Hinoda Y et al. (1994) Failure of combination therapy with recombinant
granulocyte colony-stimulating factor and erythropoietin in myelodysplastic syndromes.
Ann
Hematol
68:163-166
69 Anonymous (1998) A randomized double-blind placebo-controlled study with subcutaneous
recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. Italian
Cooperative Study Group for rHuEpo in Myelodysplastic Syndromes.
Br J Haematol
103:
1070-1074
70 Isnard F, Najman A, Jaar B, Fenaux P, Baillou C, Khoury E, Labopin M, Laporte JP, Woler M,
Gorin NC et al. (1994) Efficacy of recombinant human erythropoietin in the treatment of refracto-
ry anemias without excess of blasts in myelodysplastic syndromes.
Leuk Lymphoma
12: 307-314
